Wells Fargo’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Wells Fargo’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35	Closed	-$187	–	7775
2023 Q4	$187	Buy	35 +4	+13%	+$25	﹤0.01%	6627
2023 Q3	$250	Buy	31 +9	+41%	+$53	﹤0.01%	6530
2023 Q2	$95	Sell	22 -581	-96%	-$3.29K	﹤0.01%	6880
2023 Q1	$3.39K	Buy	+603	New	+$4.58K	﹤0.01%	6138
2022 Q4	–	Sell	-52	Closed	-$2K	–	7813
2022 Q3	$2K	Sell	52 -28	-35%	-$1.04K	﹤0.01%	6227
2022 Q2	$3K	Buy	80 +64	+400%	+$4.68K	﹤0.01%	6254
2022 Q1	$2K	Hold	16	–	–	﹤0.01%	6715
2021 Q4	$4K	Buy	+16	New	+$3.55K	﹤0.01%	6777

Wells Fargo's SNCE Position: Q1 2024 in Review

Wells Fargo sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 35 shares — an estimated $187 sold.

Wells Fargo first reported a position in SNCE in Q4 2021 and held it in 8 quarters. The position peaked at $4K in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Wells Fargo reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Wells Fargo sold 35 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $187.
Wells Fargo first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Wells Fargo's Science 37 Holdings, Inc. Common Stock position peaked at $4K in Q4 2021.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.